These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26481970)

  • 21. Drug resistance to targeted therapies: déjà vu all over again.
    Groenendijk FH; Bernards R
    Mol Oncol; 2014 Sep; 8(6):1067-83. PubMed ID: 24910388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focus issue: Rendering resistance futile.
    Adler EM; Gough NR
    Sci Signal; 2011 Mar; 4(166):eg3. PubMed ID: 21447795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks.
    Araujo RP; Liotta LA; Petricoin EF
    Nat Rev Drug Discov; 2007 Nov; 6(11):871-80. PubMed ID: 17932492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient noise amplification and gene expression synchronization in a bistable mammalian cell-fate switch.
    Palani S; Sarkar CA
    Cell Rep; 2012 Mar; 1(3):215-24. PubMed ID: 22832195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor.
    Won JK; Yang HW; Shin SY; Lee JH; Heo WD; Cho KH
    J Mol Cell Biol; 2012 Jun; 4(3):153-63. PubMed ID: 22561840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mathematical modelling suggests a differential impact of β-transducin repeat-containing protein paralogues on Wnt/β-catenin signalling dynamics.
    Benary U; Kofahl B; Hecht A; Wolf J
    FEBS J; 2015 Mar; 282(6):1080-96. PubMed ID: 25601154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
    Shin SY; Rath O; Choo SM; Fee F; McFerran B; Kolch W; Cho KH
    J Cell Sci; 2009 Feb; 122(Pt 3):425-35. PubMed ID: 19158341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptotanshinone Induces Cell Death in Lung Cancer by Targeting Aberrant Feedback Loops.
    Vundavilli H; Datta A; Sima C; Hua J; Lopes R; Bittner M
    IEEE J Biomed Health Inform; 2020 Aug; 24(8):2430-2438. PubMed ID: 31825884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
    Prahallad A; Bernards R
    Oncogene; 2016 Mar; 35(9):1073-9. PubMed ID: 25982281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulatory circuits for hysteretic switching in cellular signal transduction pathways.
    Kim JR; Cho KH
    FEBS J; 2012 Sep; 279(18):3329-37. PubMed ID: 22564788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic analysis of signaling reactivation and drug resistance.
    Kholodenko BN; Rauch N; Kolch W; Rukhlenko OS
    Cell Rep; 2021 May; 35(8):109157. PubMed ID: 34038718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feedback regulation of EGFR signalling: decision making by early and delayed loops.
    Avraham R; Yarden Y
    Nat Rev Mol Cell Biol; 2011 Feb; 12(2):104-17. PubMed ID: 21252999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multistability, oscillations and bifurcations in feedback loops.
    Leite MC; Wang Y
    Math Biosci Eng; 2010 Jan; 7(1):83-97. PubMed ID: 20104950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
    Perego P; Cossa G; Zuco V; Zunino F
    Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two forms of feedback inhibition determine the dynamical state of a small hippocampal network.
    Zeldenrust F; Wadman WJ
    Neural Netw; 2009 Oct; 22(8):1139-58. PubMed ID: 19679445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer robustness: tumour tactics.
    Kitano H
    Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.